17th Nov 2015 11:21
LONDON (Alliance News) - Medical research organisation Cyprotex PLC on Tuesday said it has launched the chemTox virtual screening product, which will predict genotoxicity directly from a chemical structure.
The company said the new product will allow users to predict both pre-clinical safety and human exposure in combination.
"The ethical concerns over animal testing are intensifying and new approaches which reduce or in the future replace animal safety testing are a key focus. Virtual screening tools such as chemTox address this need, and are becoming widely used in industries such as cosmetics and personal care where a complete ban on animal testing has been enforced," said Chief Executive Anthony Baxter.
Shares in Cyprotex were down 1.0% to 83.20 pence on Tuesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CRX.L